Closed pleural needle biopsy: predicting diagnostic yield by examining pleural fluid parameters

Pleural effusions are common in clinical practice and often require invasive diagnostic methods. Closed pleural needle biopsy is one such method, but its diagnostic yield varies. Prior research has shown that not all biopsies lead to a definitive diagnosis. This gap motivated the search for reliable indicators to predict biopsy outcomes. Existing studies lack a consistent marker for biopsy success. Understanding which fluid parameters correlate with diagnostic yield could improve patient care. No prior work had resolved the issue of selecting the best candidates for this procedure. This uncertainty drives the need for more precise predictive tools. The challenge lies in identifying which fluid characteristics are most informative. The goal is to reduce unnecessary procedures and guide clinicians toward more effective diagnostic strategies.

This study aimed to evaluate which pleural fluid parameters best predict the diagnostic yield of closed pleural needle biopsy. The researchers focused on a specific clinical problem: how to decide whether to perform a biopsy or proceed to a more invasive method. The motivation was to find a reliable, non-invasive way to guide diagnostic decisions. The team compared fluid parameters between patients with diagnostic and non-diagnostic outcomes. They sought to identify a single parameter that could serve as a predictive tool. The study was designed to inform clinical practice with data-driven insights. The researchers hypothesized that certain fluid markers would show strong correlations with biopsy results. Their goal was to provide a practical reference for clinicians managing pleural effusions.

The researchers conducted a retrospective analysis of clinical data from 44 patients who underwent closed pleural needle biopsy. They collected pleural fluid samples and measured several biochemical parameters. These included protein, glucose, lactate dehydrogenase (LDH), pH, and white blood cell count. They also analyzed differential cell counts from the same samples. The team compared these values between patients with diagnostic and non-diagnostic results. Statistical analysis was used to determine which parameters showed significant differences. The focus was on identifying a single marker with high predictive value. The study was conducted at a single institution to ensure data consistency.

The study found that LDH levels in pleural fluid were significantly higher in patients with diagnostic biopsies. Patients with non-diagnostic biopsies had lower LDH levels on average. The threshold of 510 U l(-1) was identified as a strong predictor of a negative biopsy. At this cutoff, the negative predictive value was 86.6%. Thirteen patients (29%) had diagnostic results, while 31 had non-diagnostic findings. Ten patients with non-diagnostic biopsies were later found to have malignancies. One patient died from unrelated causes, and 19 had benign outcomes. These findings suggest that LDH levels can guide decisions about biopsy necessity.

The authors propose that LDH levels in pleural fluid may serve as a useful guide for clinicians. They suggest that low LDH levels are highly predictive of a negative biopsy result. This could help reduce the number of unnecessary procedures. The study supports the use of LDH as a decision-making tool in clinical practice. The researchers emphasize that this finding is based on their specific dataset. They do not claim that LDH is the only factor to consider. Their results suggest that further validation in larger studies is warranted. The authors do not recommend changing current guidelines without additional evidence.